Carregant...
Breaking barriers to novel analgesic drug development
Acute and chronic pain complaints, while very common, are generally poorly served by existing therapies. The unmet clinical need reflects the failure in developing novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently availabl...
Guardat en:
| Publicat a: | Nat Rev Drug Discov |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675565/ https://ncbi.nlm.nih.gov/pubmed/28596533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2017.87 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|